The stock of GoodRx Holdings Inc (NASDAQ: GDRX) has decreased by -3.29 when compared to last closing price of 4.86. Despite this, the company has experienced a -4.08% fall in its stock price over the last five trading sessions. cnbc.com reported 2024-12-05 that Prescription fills for blockbuster weight loss medications in the U.S. more than doubled in 2024, even with limited insurance coverage and high out-of-pocket costs for the treatments. That’s according to new data from drug savings company GoodRx, which examined fill trends and spending patterns for weight loss drugs such as Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound.
Is It Worth Investing in GoodRx Holdings Inc (NASDAQ: GDRX) Right Now?
The 36-month beta value for GDRX is at 1.29. Analysts have varying views on the stock, with 6 analysts rating it as a “buy,” 2 rating it as “overweight,” 7 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for GDRX is 85.81M, and currently, shorts hold a 8.67% of that float. The average trading volume for GDRX on December 13, 2024 was 1.32M shares.
GDRX’s Market Performance
GDRX’s stock has seen a -4.08% decrease for the week, with a 0.00% drop in the past month and a -39.35% fall in the past quarter. The volatility ratio for the week is 3.29%, and the volatility levels for the past 30 days are at 4.83% for GoodRx Holdings Inc The simple moving average for the last 20 days is -0.28% for GDRX stock, with a simple moving average of -33.69% for the last 200 days.
Analysts’ Opinion of GDRX
Many brokerage firms have already submitted their reports for GDRX stocks, with Mizuho repeating the rating for GDRX by listing it as a “Neutral.” The predicted price for GDRX in the upcoming period, according to Mizuho is $5 based on the research report published on December 04, 2024 of the current year 2024.
Raymond James, on the other hand, stated in their research note that they expect to see GDRX reach a price target of $10. The rating they have provided for GDRX stocks is “Strong Buy” according to the report published on August 09th, 2024.
RBC Capital Mkts gave a rating of “Outperform” to GDRX, setting the target price at $10 in the report published on May 23rd of the current year.
GDRX Trading at -17.08% from the 50-Day Moving Average
After a stumble in the market that brought GDRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -49.24% of loss for the given period.
Volatility was left at 4.83%, however, over the last 30 days, the volatility rate increased by 3.29%, as shares surge +0.86% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -33.43% lower at present.
During the last 5 trading sessions, GDRX fell by -4.08%, which changed the moving average for the period of 200-days by -27.36% in comparison to the 20-day moving average, which settled at $4.71. In addition, GoodRx Holdings Inc saw -29.85% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GDRX starting from Bradley Julie MB, who proposed sale 95,255 shares at the price of $4.95 back on Dec 02 ’24. After this action, Bradley Julie MB now owns shares of GoodRx Holdings Inc, valued at $471,451 using the latest closing price.
Spectrum Equity VII, L.P., the 10% Owner of GoodRx Holdings Inc, sale 10,677 shares at $7.86 during a trade that took place back on Sep 03 ’24, which means that Spectrum Equity VII, L.P. is holding 0 shares at $83,922 based on the most recent closing price.
Stock Fundamentals for GDRX
Current profitability levels for the company are sitting at:
- 0.06 for the present operating margin
- 0.84 for the gross margin
The net margin for GoodRx Holdings Inc stands at -0.01. The total capital return value is set at 0.04. Equity return is now at value -2.06, with -1.06 for asset returns.
Based on GoodRx Holdings Inc (GDRX), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at 2.72. The debt to equity ratio resting at 0.08. The interest coverage ratio of the stock is 0.82.
Currently, EBITDA for the company is 112.93 million with net debt to EBITDA at -2.51. When we switch over and look at the enterprise to sales, we see a ratio of 1.8. The receivables turnover for the company is 6.04for trailing twelve months and the total asset turnover is 0.58. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.48.
Conclusion
In conclusion, GoodRx Holdings Inc (GDRX) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
